Efficacy and safety of tirzepatide in overweight and obese individuals with type 1 diabetes
A new study in the peer-reviewed journal Diabetes Technology & Therapeutics (DTT) evaluated the use of tirzepatide in overweight/obese adults with type 1 diabetes. Click here to read the article now.
Credit: Mary Ann Liebert, Inc., publishers
A...
New center positions UC Riverside as a leader in quantum vibronics
RIVERSIDE, Calif. — Physicist Nathaniel Gabor at the University of California, Riverside, has been awarded a $7.5M grant from the Department of Defense, or DoD, to develop a Multidisciplinary University Research Initiatives, or MURI, center on campus. Called QuVET...
snRNA-seq Reveals Remarkable Cellular and Molecular Overlap between ALS and FTLD
A research team led by scientists at MIT and at the Mayo Clinic has identified what they say are remarkable overlaps at the cellular and molecular levels between the movement disorder amyotrophic lateral sclerosis...
Accumulation of ‘junk proteins’ identified as one cause of aging and possible source of...
Amyotrophic lateral sclerosis (ALS) is a degenerative disease. The neurons responsible for movement begin to die and muscle control is progressively lost, leading to a fatal outcome. The causes of ALS are currently unknown,...
Researchers devise novel technique for crafting human artificial chromosomes
Human artificial chromosomes (HACs) capable of working within human cells could power advanced gene therapies, including those addressing some cancers, along with many laboratory applications, though serious technical obstacles have hindered their development. Now...
Branched chain amino acid supplementation speeds concussion recovery in adolescents
A new study in the peer-reviewed Journal of Neurotrauma found a significant reduction in total symptom score and faster return to physical activity among adolescents and young adults with concussion who were treated with branched chain...
Lonza to Buy Genentech’s Vacaville, CA Biologics Manufacturing Site for $1.2B
Lonza has agreed to acquire Genentech’s large-scale biologics manufacturing site in Vacaville, CA, from Genentech’s parent Roche for $1.2 billion, the companies said, in a deal designed to significantly increase the buyer’s capacity for...
Connecting computers so they can think faster
We are used to computers getting faster and faster, but complicated calculations involving lots of data can take a very long time, even today.
Credit: Photo: Per Henning, NTNU.
We are used to computers getting faster...
From farm to pharmacy: Transgenic cow milk as a new source of human insulin
In a recent study published in the Biotechnology Journal, a team of researchers from Brazil constructed a lentivirus vector with expression specific for mammary glands and carrying the gene for human insulin. They also...
On the Lookout: Prometheus Veterans Launch Mirador Therapeutics With $400 Million
After being bought out by Merck in June 2023 for nearly $11 billion, some of the ex-brass from Prometheus Biosciences headed to a spear-shaped peninsula in Mexico surrounded on three sides by white sand...
